Vor Biopharma (NYSE:VOR) Receives Outperform Rating from Wedbush
Wedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research note released on Thursday morning,RTT News reports. The brokerage currently has a $7.00 price objective on the stock. A number of other equities research analysts also recently weighed in on VOR. HC Wainwright reiterated a “buy” rating and […]
Wedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research note released on Thursday morning,RTT News reports. The brokerage currently has a $7.00 price objective on the stock. A number of other equities research analysts also recently weighed in on VOR. HC Wainwright reiterated a “buy” rating and […]
